相关实验视频

Updated: Sep 8, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

调节乳腺癌演变的Tβ4/SLC7A11信号通路的机制研究

Zhaoyan Jin¹, Hongshu Li¹, Jiafeng Li¹

¹Department of Central Laboratory, Yanbian University Hospital, Yanji, PR China; Department of Pathology and Cancer Research Center, Yanbian University, Yanji, China.

Cellular signalling

|September 5, 2025

概括

蒂莫素β4 (Tβ4) 通过上调SLC7A11来驱动乳腺癌的生长,而SLC7A11阻断铁. 针对这种Tβ4/SLC7A11通路可以克服乳腺癌的治疗耐药性.

科学领域:

癌症学
分子生物学
生物化学

背景情况:

胸蛋白β4 (Tβ4) 参与乳腺癌的进展,但其精确的分子机制尚未完全理解.
乳腺癌组织中的高Tβ4表达与不良临床结果相关,这表明Tβ4在恶性瘤中起着重要作用.

研究的目的:

阐明提莫辛β4 (Tβ4) 有助于乳腺癌进展的分子机制.
研究Tβ4在调节癌细胞增殖,迁移和铁亡等行为中的作用.

主要方法:

在乳腺癌组织和细胞系中对Tβ4表达的定量分析.
在体外和体内功能测试以评估Tβ4对癌细胞增殖,迁移,EMT,血管生成和细胞亡的影响.
包括SLC7A11在内的Tβ4直接点的鉴定和验证.
救援实验以确认Tβ4/SLC7A11轴在调解瘤效应中的作用.

主要成果:

乳腺癌的Tβ4显著上升,并与预后不佳有关.
Tβ4 增强乳腺癌细胞的增殖,迁移,上皮- 介质细胞转换 (EMT) 和血管生成,同时抑制细胞亡.
Tβ4直接上调SLC7A11的表达,导致谷氨的合成增加和抑制脂质过氧化,从而抑制铁.
沉默SLC7A11在体外和体内逆转了Tβ4的前瘤作用.

结论:

鉴定出一种新型的Tymosin β4 (Tβ4) / SLC7A11信号轴,通过抑制铁死来促进乳腺癌恶性.
这种Tβ4/SLC7A11通路是克服乳腺癌耐药性的潜在治疗标.

关键词:

乳腺癌铁症其他类型甲胺β4 (Tβ4)

更多相关视频

Spheroid Assay to Measure TGF-β-induced Invasion

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Canonical Wnt Signaling Pathway

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Non-Canonical Wnt Signaling Pathways

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...